Conferences

Catalog

Abstracts

Calendar

6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy

Accreditation: 10.00 AMA PRA Category 1 Credit™ | 10.00 ABIM MOC II | 10.00 Nursing Contact Hours | 10.00 ACPE Pharmacy

Venue: Hyatt Regency San Francisco Downtown SOMA, 50 3rd Street, San Francisco, CA, United States

Start Date: September 11End Date: September 12, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

27+

Email if you have questions

Our Speakers

Planning Committee

James M. Ford, MD

Conference Co-Chair

Stanford University

Milana v Dolezal, MD

Abstract Committee

Stanford School of Medicine

William Shomali, MD

Abstract Committee

Stanford University

Faculty

Milana v Dolezal, MD

Associate Chair

Stanford School of Medicine

Sachdev P Thomas, MD

Associate Chair

Kaiser Permanente

Varun Monga, MD, MBBS

Associate Chair

University of California San Francisco

Siddhartha Yadav, MD

Topic Presenter

Mayo Clinic

Naoto Ueno, MD, PhD, FACP

Topic Presenter

University of Hawai'i Cancer Center

Andrei Iagaru, MD

Topic Presenter

Stanford Health Care

Our Agenda

Day 1: Friday, September 11th, 2026

All timings are in Pacific Time (PDT, GMT-07:00) time.

09:00 AM - 10:00 AMRegistration, Breakfast, & Exhibits

10:00 AM - 10:30 AMSession 1: Key Note Address

10:00 AM - 10:30 AM

Target Discovery and Validation – Dennis Slamon, MD, PhD

10:30 AM - 11:45 AM Germline Alterations in Human Cancers

Session Chair: Pamela Munster, MD

10:30 AM - 10:45 AM

Overview of germline vs. somatic mutations in cancer predisposition - Role in therapy selection across tumor types – Siddhartha Yadav, MD

10:45 AM - 11:00 AM

Current targeted therapies for germline alterations – Melinda L. Telli, MD

11:00 AM - 11:15 AM

Near-Future Pipeline Agents Targeting Germline DNA alterations in Cancer Medicine

11:15 AM - 11:30 AM

VHL-targeted: Belzutifan for RCC/Pheo – James Brugarolas, MD, MD

11:30 AM - 11:45 AM

Panel Discussion

11:45 AM - 01:00 PMMolecular Diagnostics in Precision Oncology

11:45 AM - 12:00 PM

NHS-Galleri Trial

12:00 PM - 12:15 PM

Sensitive Detection of MRD in Early-stage Cancer – Milana v Dolezal, MD

12:15 PM - 12:30 PM

Controversies in Treatment-emergent Drug Resistance Mutations: Intervention Prior to RECIST Disease Progression – Pedram Razavi, MD PhD

12:30 PM - 01:00 PM

Panel Discussion

01:00 PM - 02:00 PMLunch & Exhibits

01:00 PM - 01:45 PMResearch Poster Presentation

02:00 PM - 03:00 PMAntibody-based Therapeutics

Session Chair: Arun Wiita, MD, PhD

02:00 PM - 02:15 PM

Novel ADC Linker/Payload Considerations – Mark Daniel Pegram, MD

02:15 PM - 02:30 PM

Therapeutic strategies targeting brain metastases – Nancy Lin, MD

02:30 PM - 03:00 PM

Panel Discussion

03:00 PM - 03:20 PMBreak & Exhibits

03:20 PM - 04:20 PMMolecular Tumor Board 1: Interesting and Challenging Cases in Precision Oncology

Session Chair: James M. Ford, MD

04:20 PM - 05:35 PMDrug Resistance in Precision Oncology

Session Chair: Vivek Subbiah, MD

04:20 PM - 04:35 PM

Adaptive Feedback and Bypass Pathways – Trever Bivona, MD, PhD

04:35 PM - 04:50 PM

Mechanisms of ADC Resistance – Naoto Ueno, MD, PhD, FACP

04:50 PM - 05:05 PM

Tumor Microenvironment Role – Judith A. Varner, PhD

05:05 PM - 05:35 PM

Panel Discussion

05:35 PM - 05:35 PMAdjourn Day 1

Day 2: Saturday, September 12th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast & Exhibits

About 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Our Agenda

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship

Our Speakers

Planning Committee

Faculty

Our Agenda